Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2011 2
2012 2
2013 4
2014 1
2015 6
2016 8
2017 13
2018 4
2019 14
2020 28
2021 21
2022 20
2023 18
2024 19
2025 12

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

151 results

Results by year

Filters applied: . Clear all
Page 1
Non-small-cell lung cancer.
Hendriks LEL, Remon J, Faivre-Finn C, Garassino MC, Heymach JV, Kerr KM, Tan DSW, Veronesi G, Reck M. Hendriks LEL, et al. Among authors: remon j. Nat Rev Dis Primers. 2024 Sep 26;10(1):71. doi: 10.1038/s41572-024-00551-9. Nat Rev Dis Primers. 2024. PMID: 39327441 Review.
MET alterations in NSCLC-Current Perspectives and Future Challenges.
Remon J, Hendriks LEL, Mountzios G, García-Campelo R, Saw SPL, Uprety D, Recondo G, Villacampa G, Reck M. Remon J, et al. J Thorac Oncol. 2023 Apr;18(4):419-435. doi: 10.1016/j.jtho.2022.10.015. Epub 2022 Oct 29. J Thorac Oncol. 2023. PMID: 36441095 Free article. Review.
Lung Cancer in Spain.
Remon J, Reguart N, García-Campelo R, Conde E, Lucena CM, Persiva O, Navarro-Martin A, Rami-Porta R. Remon J, et al. J Thorac Oncol. 2021 Feb;16(2):197-204. doi: 10.1016/j.jtho.2020.09.026. Epub 2020 Oct 24. J Thorac Oncol. 2021. PMID: 33109473 Free article. No abstract available.
Association of the Lung Immune Prognostic Index With Immune Checkpoint Inhibitor Outcomes in Patients With Advanced Non-Small Cell Lung Cancer.
Mezquita L, Auclin E, Ferrara R, Charrier M, Remon J, Planchard D, Ponce S, Ares LP, Leroy L, Audigier-Valette C, Felip E, Zerón-Medina J, Garrido P, Brosseau S, Zalcman G, Mazieres J, Caramela C, Lahmar J, Adam J, Chaput N, Soria JC, Besse B. Mezquita L, et al. Among authors: remon j. JAMA Oncol. 2018 Mar 1;4(3):351-357. doi: 10.1001/jamaoncol.2017.4771. JAMA Oncol. 2018. PMID: 29327044 Free PMC article.
Impact of pembrolizumab treatment duration on overall survival and prognostic factors in advanced non-small cell lung cancer: a nationwide retrospective cohort study.
Rousseau A, Michiels S, Simon-Tillaux N, Lolivier A, Bonastre J, Planchard D, Barlesi F, Remon J, Lavaud P, Aldea M, Frelaut M, Le Pechoux C, Botticella A, Levy A, Gazzah A, Foulon S, Besse B. Rousseau A, et al. Among authors: remon j. Lancet Reg Health Eur. 2024 Jun 29;43:100970. doi: 10.1016/j.lanepe.2024.100970. eCollection 2024 Aug. Lancet Reg Health Eur. 2024. PMID: 39040528 Free PMC article.
An international and multidisciplinary EORTC survey on resectability of stage III non-small cell lung cancer.
Houda I, Bahce I, Dickhoff C, Kroese TE, Kroeze SGC, Mariolo AV, Tagliamento M, Moliner L, Brandão M, Pretzenbacher Y, Edwards J, Opitz I, Brunelli A, Guckenberger M, van Schil PE, Popat S, Blum T, Faivre-Finn C, de Ruysscher D, Remon J, Berghmans T, Dingemans AC, Besse B, Hendriks LEL. Houda I, et al. Among authors: remon j. Lung Cancer. 2025 Jan;199:108061. doi: 10.1016/j.lungcan.2024.108061. Epub 2024 Dec 15. Lung Cancer. 2025. PMID: 39705827 Free article.
151 results